Educational Session Speakers

Dr. Keith Lim

Dr Keith Lim graduated from the National University of Singapore and obtained his post graduate fellowship in Radiation Oncology from the Royal Australian, New Zealand College of Radiology (RANZCR). Dr Lim’s sub-specialty interests are in central nervous system and prostate cancer, where he has pioneered the use of high dose rate prostate brachytherapy in Singapore. Aside from being a Senior Consultant in at the National University Cancer Institute of Singapore, Dr Lim is also one of the Deputy Chief Medical Information Officers for the National University Hospital.

Dr. Lim has been published in numerous peer-reviewed journals and has been awarded several national competitive research grants.

Dr. Lim is very active in the field of medical education. He is presently an Assistant Dean with the Yong Loon Lin School of Medicine, National University of Singapore, the co-chairman of the NUS Inter-professional Education Committee as well as the academic lead for several of medical school’s clinical programs. He is a member of the Residency Advisor Committee for Singapore’s national radiation oncology training program and he has previously served as the Vice President of the Singapore Society of Oncologists.

Dr Lim presently leads the Value driven Outcome initiative for NUHS which aims to ensure patients receive the best quality care by monitoring the level of care delivered and the cost it takes to achieve this.

Dr. Keith Lim

Dr Keith Lim graduated from the National University of Singapore and obtained his post graduate fellowship in Radiation Oncology from the Royal Australian, New Zealand College of Radiology (RANZCR). Dr Lim’s sub-specialty interests are in central nervous system and prostate cancer, where he has pioneered the use of high dose rate prostate brachytherapy in Singapore. Aside from being a Senior Consultant in at the National University Cancer Institute of Singapore, Dr Lim is also one of the Deputy Chief Medical Information Officers for the National University Hospital.

Dr. Lim has been published in numerous peer-reviewed journals and has been awarded several national competitive research grants.

Dr. Lim is very active in the field of medical education. He is presently an Assistant Dean with the Yong Loon Lin School of Medicine, National University of Singapore, the co-chairman of the NUS Inter-professional Education Committee as well as the academic lead for several of medical school’s clinical programs. He is a member of the Residency Advisor Committee for Singapore’s national radiation oncology training program and he has previously served as the Vice President of the Singapore Society of Oncologists.

Dr Lim presently leads the Value driven Outcome initiative for NUHS which aims to ensure patients receive the best quality care by monitoring the level of care delivered and the cost it takes to achieve this.

Research and analysis for a better living


Dr Ngiam Kee Yuan

Dr Ngiam is a Consultant at the Division of General Surgery (Thyroid and Endocrine Surgery) at the National University Hospital, specialising in Thyroid and Endocrine surgical disorders. Following the completion of his Advanced Specialist Training in General Surgery, he was awarded a fellowship from the Royal College of Surgeons of Edinburgh and was accredited as a surgical specialist by the Specialist Accreditation Board, Singapore in 2012. He received the Higher Manpower Development Program Award in 2012 to complete a Fellowship in Metabolic and Endocrine Surgery in Taiwan. He received further training in robotic thyroid surgery at the Seoul National University Hospital, South Korea.

Dr Ngiam’s special interests are in thyroid and endocrine surgery, robotic thyroid surgery, bariatric and metabolic surgery, advanced endoscopy and laparoscopic surgery. He was awarded the ExxonMobil-NUS Research Fellowship for Clinicians in 2007 and his research interests include parathyroid surgery, robotic thyroid surgery, obesity surgery for type 2 diabetes and thyroid cancer surgery.

Dr Ngiam Kee Yuan

Dr Ngiam is a Consultant at the Division of General Surgery (Thyroid and Endocrine Surgery) at the National University Hospital, specialising in Thyroid and Endocrine surgical disorders. Following the completion of his Advanced Specialist Training in General Surgery, he was awarded a fellowship from the Royal College of Surgeons of Edinburgh and was accredited as a surgical specialist by the Specialist Accreditation Board, Singapore in 2012. He received the Higher Manpower Development Program Award in 2012 to complete a Fellowship in Metabolic and Endocrine Surgery in Taiwan. He received further training in robotic thyroid surgery at the Seoul National University Hospital, South Korea.

Dr Ngiam’s special interests are in thyroid and endocrine surgery, robotic thyroid surgery, bariatric and metabolic surgery, advanced endoscopy and laparoscopic surgery. He was awarded the ExxonMobil-NUS Research Fellowship for Clinicians in 2007 and his research interests include parathyroid surgery, robotic thyroid surgery, obesity surgery for type 2 diabetes and thyroid cancer surgery.

Advanced Technology to a healing touch


A/Prof Mikael Hartman

A/Prof Mikael Hartman has been practicing in Singapore since 2009 and is originally from Stockholm, Sweden where he received his training at Karolinska Institute. That is also where he received his board certification in General Surgery in 2005. Having completed his doctoral studies in the field of epidemiology in 2007, he specializes in the field of breast cancer etiology and prognostification as well as inheritance of cancer prognosis. He has been a co-recipient of the Breast Cancer Concept Award, US Army, in 2002 and 2006.

He heads a research group of more than ten members including three PhD students and is leading the development of the Singapore Breast Cancer Cohort and the Singapore-Malaysia Breast Cancer Working Group and the Breast Cancer Prevention Programme in the Saw Swee Hock School of Public Health (SSHSPH). The research has been published in Lancet Oncology, Journal of Clinical Oncology, Breast Cancer Research, British Journal of Surgery, European Journal of Cancer etc. He serves as the Deputy Director of the Initiative for Research and Innovation in Surgery – NUHS, the Research Director of the University Surgical Cluster Research Committee – NUHS, the Head of Surgical Clinical Epidemiology Unit – NUHS, Deputy Head of Breast Services in Department of Surgery – NUH and a member of SSHSPH Senior Management Committee and Faculty Promotion and Tenure Committee.

He is a father of 3 children with a keen interest in skiing, hiking and mountain biking. In 2014 he made an effort to create awareness for breast cancer and research by riding a motorcycle from Singapore to Sweden.

A/Prof Mikael Hartman

A/Prof Mikael Hartman has been practicing in Singapore since 2009 and is originally from Stockholm, Sweden where he received his training at Karolinska Institute. That is also where he received his board certification in General Surgery in 2005. Having completed his doctoral studies in the field of epidemiology in 2007, he specializes in the field of breast cancer etiology and prognostification as well as inheritance of cancer prognosis. He has been a co-recipient of the Breast Cancer Concept Award, US Army, in 2002 and 2006.

He heads a research group of more than ten members including three PhD students and is leading the development of the Singapore Breast Cancer Cohort and the Singapore-Malaysia Breast Cancer Working Group and the Breast Cancer Prevention Programme in the Saw Swee Hock School of Public Health (SSHSPH). The research has been published in Lancet Oncology, Journal of Clinical Oncology, Breast Cancer Research, British Journal of Surgery, European Journal of Cancer etc. He serves as the Deputy Director of the Initiative for Research and Innovation in Surgery – NUHS, the Research Director of the University Surgical Cluster Research Committee – NUHS, the Head of Surgical Clinical Epidemiology Unit – NUHS, Deputy Head of Breast Services in Department of Surgery – NUH and a member of SSHSPH Senior Management Committee and Faculty Promotion and Tenure Committee.

He is a father of 3 children with a keen interest in skiing, hiking and mountain biking. In 2014 he made an effort to create awareness for breast cancer and research by riding a motorcycle from Singapore to Sweden.

Cancer research for improved treatment


Prof Patrick Tan

Prof. Patrick Tan is a Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology, and Research). He directs PRISM, the SingHealth DukeNUS Institute of Precision Medicine, and was Program Director of POLARIS, which established the first CAP-certified facilities for next-generation sequencing and the first clinically implemented NGS panel in South East Asia. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), SingHealth Investigator Excellence Award, Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a national body that provides advice to the Singapore government on ethical issues related to biomedical research, a Board Member of the International Gastric Cancer Association, and a Member of the AACR International Affairs Committee. He co-leads the biliary tract cancer project of the International Cancer Genome Consortium (ICGC), and is co-chair of the Singapore National Precision Medicine Program Steering Committee.

Prof Patrick Tan

Prof. Patrick Tan is a Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology, and Research). He directs PRISM, the SingHealth DukeNUS Institute of Precision Medicine, and was Program Director of POLARIS, which established the first CAP-certified facilities for next-generation sequencing and the first clinically implemented NGS panel in South East Asia. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), SingHealth Investigator Excellence Award, Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a national body that provides advice to the Singapore government on ethical issues related to biomedical research, a Board Member of the International Gastric Cancer Association, and a Member of the AACR International Affairs Committee. He co-leads the biliary tract cancer project of the International Cancer Genome Consortium (ICGC), and is co-chair of the Singapore National Precision Medicine Program Steering Committee.